前列腺素E系列（PGE）正在被越来越多地用于治疗急性和慢性肝病患者。前列腺素是细胞保护因子，已显示对各种急性和慢性肝病患者有益。然而很少有关于前列腺素对这些患者的副作用发生率的资料，作者进行了一项研究，以调查在这些患者中PGE治疗的副作用发生率和性质以及总的安全 Prostaglandin E Series (PGE) is increasingly being used to treat patients with acute and chronic liver disease. Prostaglandins are cytoprotective factors that have been shown to be beneficial in a variety of acute and chronic liver disease patients. However, with little data on the incidence of prostaglandin in these patients, the authors conducted a study to investigate the incidence and nature of side effects of PGE treatment in these patients and the overall safety